Investor Presentation Q3 2021 Financial and Business Update Q2 2021 Financial and Business Update Development Program for Pitolisant in Patients with Myotonic Dystrophy (DM) Development Program for Pitolisant in Patients with Myotonic Dystrophy (DM) MP3 Q1 2021 Financial and Business Update
